A detailed history of Capital World Investors transactions in Zoetis Inc. stock. As of the latest transaction made, Capital World Investors holds 6,683,979 shares of ZTS stock, worth $1.18 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,683,979
Previous 6,783,377 1.47%
Holding current value
$1.18 Billion
Previous $1.18 Billion 11.05%
% of portfolio
0.21%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$172.58 - $196.48 $17.2 Million - $19.5 Million
-99,398 Reduced 1.47%
6,683,979 $1.31 Billion
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $71.5 Million - $87.8 Million
491,070 Added 7.8%
6,783,377 $1.18 Billion
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $459 Million - $554 Million
-2,771,851 Reduced 30.58%
6,292,307 $1.06 Billion
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $8.75 Million - $11.6 Million
57,798 Added 0.64%
9,064,158 $1.79 Billion
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $24.3 Million - $28.1 Million
145,528 Added 1.64%
9,006,360 $1.57 Billion
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $524,503 - $606,923
-3,259 Reduced 0.04%
8,860,832 $1.53 Billion
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $22.7 Million - $27.3 Million
-156,056 Reduced 1.73%
8,864,091 $1.48 Billion
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $9.14 Million - $11 Million
69,731 Added 0.78%
9,020,147 $1.32 Billion
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $758,503 - $933,743
-5,115 Reduced 0.06%
8,950,416 $1.33 Billion
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $5.88 Million - $7.54 Million
-37,684 Reduced 0.42%
8,955,531 $1.54 Billion
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $7.44 Million - $9.6 Million
-41,014 Reduced 0.45%
8,993,215 $1.7 Billion
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $77,282 - $98,564
399 Added 0.0%
9,034,229 $2.2 Billion
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $27.9 Million - $30.9 Million
-147,347 Reduced 1.6%
9,033,830 $1.75 Billion
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $4.98 Million - $6 Million
31,935 Added 0.35%
9,181,177 $1.71 Billion
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $26 Million - $30.6 Million
180,717 Added 2.02%
9,149,242 $1.44 Billion
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $3.1 Million - $3.44 Million
19,719 Added 0.22%
8,968,525 $1.48 Billion
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $71 Million - $85.6 Million
-517,516 Reduced 5.47%
8,948,806 $1.48 Billion
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $485,956 - $618,865
-4,342 Reduced 0.05%
9,466,322 $1.3 Billion
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $12.6 Million - $19.7 Million
-135,670 Reduced 1.41%
9,470,664 $1.11 Billion
Q4 2019

Feb 18, 2020

SELL
$116.25 - $133.25 $87.5 Million - $100 Million
-752,479 Reduced 7.26%
9,606,334 $1.27 Billion
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $2.78 Million - $3.17 Million
24,703 Added 0.24%
10,358,813 $1.29 Billion
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $160 Million - $187 Million
1,633,352 Added 18.77%
10,334,110 $1.17 Billion
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $116 Million - $143 Million
1,420,895 Added 19.52%
8,700,758 $876 Million
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $152,772 - $183,585
1,927 Added 0.03%
7,279,863 $623 Million
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $66.8 Million - $74.5 Million
799,515 Added 12.34%
7,277,936 $666 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $201 Million - $224 Million
2,516,691 Added 63.53%
6,478,421 $552 Million
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $3.19 Million - $3.78 Million
-44,626 Reduced 1.11%
3,961,730 $331 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $1.41 Million - $1.62 Million
-22,255 Reduced 0.55%
4,006,356 $289 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $241 Million - $263 Million
4,028,611
4,028,611 $257 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.